prepare an speech about How much vaccination is successful in India or precautions we needed under the covid 19 pandemic(and there is no need of few days results) (and no unnecessary answers)
Answers
Answer:
Vaccines for COVID-19 are critical tools for helping bring the pandemic under control when combined with effective testing and existing prevention measures. With several promising vaccine candidates in the pipeline, some under review for approval and the Pfizer/BioNTech, Moderna and Oxford-AstraZeneca vaccines approved for use by a number of stringent national regulatory bodies, the race for a safe and effective vaccine has entered into a new phase.
The threat to children posed by COVID-19 is enormous, extending far beyond the immediate physical effects of the disease. As lockdown restrictions continue or are re-imposed, children’s access to essential health services may be seriously affected. The resulting reductions in routine healthcare coverage levels and a looming recession are threatening the health and the future of a generation of children. Below are answers to some of the most common questions parents might have about COVID-19 vaccines.
Answer:
Pune-based Serum Institute of India announced that it would apply for clinical trials of certain strains from Drug Controller General of India (DCGI) in April 2020. As per company president Adar Poonawalla, a vaccine for COVID-19 will be delivered within a year. However, it may not be effective on 20 to 30% people.[4] Two other companies are also trying to develop a vaccine: Zydus Cadila, which is replicating viral vector and developing a DNA plasmid vaccine,[5] and Hyderabad-based Bharat Biotech, in collaboration with US based FluGen, which is expecting the first clinical trials of a nasal vaccine by late 2020.[6] As of late February, the Serum Institute of India had begun animal trials of vaccine candidates,[7] followed by Zydus Cadila in March.[8] ICMR partnered with Bharat Biotech in May to develop COVID vaccine completely in India.[9] Till May, there were over 30 candidates of COVID-19 vaccine in development in India, many of which were already in pre-clinical tests.[10] Per reports emerged in July, ICMR was preparing to launch BBV152 COVID vaccine or Covaxin, India's first COVID-19 vaccine on 15 August following its ongoing human trials in July.[11] Although, later deadline was cited as only meant to cut "red tape" and expected timeline of any Indian vaccine not to be before 2021.[12] COVAXIN has been reported to have positive results on animals in building immunity against COVID-19 in pre-clinical trials.[13] In mid-July, Zydus Cadila too had followed with human trials of its vaccine named ZyCoV-D.[14] In early August, SII's got approval from DCGI for trial phases II & III.[15] SII has also joined GAVI in a partnership with Bill & Melinda Gates Foundation to produce 100 million doses of vaccine for developing countries.[16]
In September, India's science minister Dr. Harsh Vardhan announced that the first vaccine for use will be available by first quarter of 2021.[17] 30 million health workers directly dealing with COVID patients, especially doctors and other medical personnel are supposed to be first to receive the vaccine.[18]
Explanation: